Abstract
We assessed for vancomycin-resistant Staphylococcus aureus (VRSA) precursor organisms in southeastern Michigan, an area known to have VRSA. The prevalence was 2.5% (pSK41-positive methicillin-resistant S. aureus, 2009-2011) and 1.5% (Inc18-positive vancomycin-resistant Enterococcus, 2006-2013); Inc18 prevalence significantly decreased after 2009 (3.7% to 0.82%). Risk factors for pSK41 included intravenous vancomycin exposure.
Publication types
-
Research Support, U.S. Gov't, P.H.S.
MeSH terms
-
Comorbidity
-
Cross Infection / epidemiology
-
Cross Infection / microbiology
-
Enterococcus faecalis / isolation & purification
-
Enterococcus faecalis / physiology
-
Female
-
Humans
-
Male
-
Methicillin-Resistant Staphylococcus aureus / isolation & purification
-
Michigan / epidemiology
-
Microbial Sensitivity Tests / methods
-
Middle Aged
-
Prevalence
-
Risk Factors
-
Staphylococcal Infections* / epidemiology
-
Staphylococcal Infections* / microbiology
-
Staphylococcus aureus* / isolation & purification
-
Staphylococcus aureus* / physiology
-
Vancomycin Resistance*